Yuchen Zhong

Changzhou, 213164, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Aptamer-Targeted PrPC Drives Colorectal Cancer Metastasis via a LYN-STAT3 Complex and Enables Liquid Biopsy Detection.

Aptamer-Targeted PrPC Drives Colorectal Cancer Metastasis via a LYN-STAT3 Complex and Enables Liquid Biopsy Detection.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 09, 2026

Corrigendum to "Click-chemistry mediated synthesis of podophyllotoxin triazole ether derivatives: Inhibiting human CRC tumor growth via dual targeting of AKT1 and tubulin" [Bioorg. Chem. 166 (2025) 109195].

Corrigendum to "Click-chemistry mediated synthesis of podophyllotoxin triazole ether derivatives: Inhibiting human CRC tumor growth via dual targeting of AKT1 and tubulin" [Bioorg. Chem. 166 (2025) 109195].

Journal: Bioorganic chemistry

Published: November 16, 2025

Click-chemistry mediated synthesis of podophyllotoxin triazole ether derivatives: Inhibiting human CRC tumor growth via dual targeting of AKT1 and tubulin.

Click-chemistry mediated synthesis of podophyllotoxin triazole ether derivatives: Inhibiting human CRC tumor growth via dual targeting of AKT1 and tubulin.

Journal: Bioorganic chemistry

Published: September 11, 2025

OSBPL3 drives colorectal cancer progression via Hippo-YAP signaling and modulates MEK inhibitor sensitivity.

OSBPL3 drives colorectal cancer progression via Hippo-YAP signaling and modulates MEK inhibitor sensitivity.

Journal: Communications biology

Published: May 12, 2025

SKA3/PTTG1/c-MYC signal loop drives the progression of colorectal cancer.

SKA3/PTTG1/c-MYC signal loop drives the progression of colorectal cancer.

Journal: Clinical and translational medicine

Published: April 08, 2024

Multi-omic analyses reveal PTPN6's impact on tumor immunity across various cancers.

Multi-omic analyses reveal PTPN6's impact on tumor immunity across various cancers.

Journal: Scientific reports

Published: January 02, 2024

Pan-cancer analysis of Sushi domain-containing protein 4 (SUSD4) and validated in colorectal cancer.

Pan-cancer analysis of Sushi domain-containing protein 4 (SUSD4) and validated in colorectal cancer.

Journal: Aging

Published: May 26, 2023

Pan-Cancer analysis and experimental validation identify the oncogenic nature of ESPL1: Potential therapeutic target in colorectal cancer.

Pan-Cancer analysis and experimental validation identify the oncogenic nature of ESPL1: Potential therapeutic target in colorectal cancer.

Journal: Frontiers in immunology

Published: January 05, 2023

DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis.

DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis.

Journal: Frontiers in oncology

Published: October 08, 2022

Short-term and long-term outcomes of natural orifice specimen extraction surgeries (NOSES) in rectal cancer: a comparison study of NOSES and non-NOSES.

Short-term and long-term outcomes of natural orifice specimen extraction surgeries (NOSES) in rectal cancer: a comparison study of NOSES and non-NOSES.

Journal: Annals of translational medicine

Published: February 14, 2022

Role of Phenotypes of Circulating Tumor Cells in the Diagnosis and Treatment of Colorectal Cancer.

Role of Phenotypes of Circulating Tumor Cells in the Diagnosis and Treatment of Colorectal Cancer.

Journal: Cancer management and research

Published: April 19, 2021

Long-Term Outcome Comparison Between Two Specimen Extraction Approaches for Middle Rectum Cancer: A Retrospective Study.

Long-Term Outcome Comparison Between Two Specimen Extraction Approaches for Middle Rectum Cancer: A Retrospective Study.

Journal: Surgical innovation

Published: March 31, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026